Hoechst Pakistan products and prices in Pakistan
Manufacturer & importer Has products under both a manufacturing licence (DML) and a sale licence (DSL). Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Public pharmaceutical company · Karachi · Pakistan
Public pharmaceutical company with more than five decades of operations in Pakistan, formerly operating under Sanofi and related legacy identities.
Hoechst Pakistan products in Pakistan
Hoechst Pakistan Limited has 63 medicine presentations registered in Pakistan under 28 brands, covering 25 generic medicines. Most of its products are in Anti-infectives, Endocrine & metabolic and Hematology & thrombosis. Its brands with the most registered strengths and packs are Flagyl (Metronidazole, Metronidazole + Diloxanide furoate), Aventriax (Ceftriaxone), Claforan (Cefotaxime) and Clexane (Enoxaparin). 63 products have an official DRAP price on MedInfoBase. See all 28 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Public pharmaceutical company
- Address
- Plot No. 23, Sector 22, Korangi Industrial Area, Karachi, Pakistan
- Website
- hoechst.com.pk ↗
- Phone
- +92 21 35060221-35
- Official contact
- Contact page ↗
- Corporate source details checked
- 31 Oct 2026
- Corporate profile completeness
- 75%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Hoechst Pakistan Limited is priced against the market
40 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Apiquis Tablet 2.5mgRegistry verified | Apixaban | — | — | — | 137117Official source ↗ | No indexed price | — | — |
| Apiquis Tablet 5mgRegistry verified | Apixaban | — | — | — | 137118Official source ↗ | No indexed price | — | — |
| Aventriax | Ceftriaxone | 250 mg | IV injection | 1 Vial (1x1) | 050375 | PKR 208.60 | PKR 208.60/vial/unit | 🔒 Pharma Pro |
| Aventriax | Ceftriaxone | 250 mg | IM injection | 1 Vial (1x1) | 050376 | PKR 208.60 | PKR 208.60/vial/unit | 🔒 Pharma Pro |
| Aventriax | Ceftriaxone | 500 mg | IM injection | 1 Vial (1x1) | 050377 | PKR 360.97 | PKR 360.97/vial/unit | 🔒 Pharma Pro |
| Aventriax | Ceftriaxone | 1 g | IM injection | 1 vial | 050378 | PKR 662.97 | PKR 662.97/vial/unit | 🔒 Pharma Pro |
| Aventriax | Ceftriaxone | 1 g | IV injection | 1 Vial (1x1) | 050379 | PKR 662.97 | PKR 662.97/vial/unit | 🔒 Pharma Pro |
| Aventriax | Ceftriaxone | 500 mg | IV injection | 1 Vial (1x1) | 053091 | PKR 360.97 | PKR 360.97/vial/unit | 🔒 Pharma Pro |
| Claforan | Cefotaxime | 250 mg | Injection | 1's | 006056 | PKR 155.45 | PKR 155.45/vial/unit | 🔒 Pharma Pro |
| Claforan | Cefotaxime | 1 g | Injection | 1's | 006058 | PKR 389.89 | PKR 389.89/vial/unit | 🔒 Pharma Pro |
| Claforan | Cefotaxime | 0.5 g | Injection | 1's | 020483 | PKR 234.92 | PKR 234.92/vial/unit | 🔒 Pharma Pro |
| Claforan | Cefotaxime | 2 g | Injection | 1's | 076156 | PKR 888.89 | PKR 888.89/vial/unit | 🔒 Pharma Pro |
| Clexane | Enoxaparin | 40 mg | Injection | 2's (1x2) | 017004 | PKR 1,834.46 | — | No comparator |
| Clexane | Enoxaparin | 60 mg | Injection | 2's (1x2) | 017809 | PKR 2,877.92 | — | No comparator |
| Clexane | Enoxaparin | 80 mg | Injection | 2's (1x2) | 017810 | PKR 3,372.43 | — | No comparator |
| Co-Plavix | Clopidogrel + Aspirin | 75 mg + 75 mg | Tablet | 10's | 075978 | PKR 535.48 | PKR 53.55/tablet | 🔒 Pharma Pro |
| Cordarone | Amiodarone | 150 mg | Injection | 1x6 | 010645 | PKR 1,091.08 | PKR 181.85/vial/unit | No comparator |
| Cordarone | Amiodarone | 200 mg | Tablet | 3x10 | 010646 | PKR 1,064.69 | PKR 35.49/tablet | 🔒 Pharma Pro |
| Cordarone | Amiodarone | 100 mg | Tablet | 2x14 | 019347 | PKR 458.78 | PKR 16.39/tablet | 🔒 Pharma Pro |
| Critixa | Ceftazidime | 2 g/0.5 g | Injection | 1's | 135240 | PKR 7,923.00 | PKR 7,923.00/vial/unit | No comparator |
| Duhuxt Tablet 150mg+10mgRegistry verified | Amlodipine Besylate Eq. to Amlodipine, Irbesartan | — | — | — | 137110Official source ↗ | No indexed price | — | — |
| Duhuxt Tablet 150mg+5mgRegistry verified | Amlodipine Besylate Eq. to Amlodipine, Irbesartan | — | — | — | 137109Official source ↗ | No indexed price | — | — |
| Duhuxt Tablet 300mg+10mgRegistry verified | Amlodipine Besylate Eq. to Amlodipine, Irbesartan | — | — | — | 137111Official source ↗ | No indexed price | — | — |
| Duhuxt Tablet 300mg+5mgRegistry verified | Amlodipine Besylate Eq. to Amlodipine, Irbesartan | — | — | — | 137112Official source ↗ | No indexed price | — | — |
| Eloxatin Concentrate | Oxaliplatin | 50 mg/10 mL | Solution for infusion | 1x1 | 044890 | PKR 23,782.93 | PKR 23,782.93/vial/unit | No comparator |
| Eloxatin Concentrate | Oxaliplatin | 100 mg/20 mL | Solution for infusion | 1x1 | 044891 | PKR 47,565.83 | PKR 47,565.83/vial/unit | No comparator |
| EmjardSource observed | Empagliflozin | 10 mg | Tablet | 2x7's | 137253Official source ↗ | No indexed price | — | — |
| Flagyl | Metronidazole | 400 mg | Tablet | 300's | 000827 | PKR 1,080.73 | PKR 3.60/tablet | 🔒 Pharma Pro |
| Flagyl | Metronidazole | 400 mg | Tablet | 20x10 | 000827 | PKR 999.45 | PKR 5.00/tablet | 🔒 Pharma Pro |
| Flagyl | Metronidazole | 200 mg | Tablet | 20 x 10 | 000910 | PKR 534.80 | PKR 2.67/tablet | 🔒 Pharma Pro |
| Flagyl | Metronidazole | 200 mg/5 mL | Suspension | 90ml Bottle | 001214 | PKR 124.20 | PKR 1.38/mL | 🔒 Pharma Pro |
| Flagyl | Metronidazole | 200 mg/5 mL | Suspension | 120ml Bottle | 001214 | PKR 162.67 | PKR 1.36/mL | 🔒 Pharma Pro |
| Flagyl | Metronidazole | 200 mg/5 mL | Suspension | 60ml Bottle | 001214 | PKR 82.81 | PKR 1.38/mL | 🔒 Pharma Pro |
| Flagyl | Metronidazole | 500 mg/100 mL | IV infusion | 100ml | 005102 | PKR 217.15 | PKR 2.17/mL | 🔒 Pharma Pro |
| Flagyl | Metronidazole + Diloxanide furoate | 400 mg + 500 mg | Tablet | 15's | 055977 | PKR 158.30 | PKR 10.55/tablet | 🔒 Pharma Pro |
| Flagyl Plus | Metronidazole + Diloxanide furoate | 200 mg + 250 mg | Suspension | 60ml Bottle | 064850 | PKR 83.95 | PKR 1.40/mL | 🔒 Pharma Pro |
| Flagyl Plus | Metronidazole + Diloxanide furoate | 200 mg + 250 mg | Suspension | 90ml Bottle | 064850 | PKR 124.74 | PKR 1.39/mL | 🔒 Pharma Pro |
| Fludara / Fludarabine Phosphate | Fludarabine phosphate | 50 mg | Powder for solution for injection | 5's | 088890 | PKR 124,754.64 | PKR 24,950.93/vial/unit | No comparator |
| Hefref Tablet 24mg/26mgRegistry verified | Sacubitril, Valsartan | — | — | — | 137254Official source ↗ | No indexed price | — | — |
| Hefref Tablet 49mg/51mgRegistry verified | Sacubitril, Valsartan | — | — | — | 137133Official source ↗ | No indexed price | — | — |
| Hefref Tablet 97mg/103mgRegistry verified | Sacubitril, Valsartan | — | — | — | 137134Official source ↗ | No indexed price | — | — |
| Hexaxim Deptheria + Tetanus + Polio + Pertussius + Influenza + Hepatitis BSource observed | — | — | Suspension for injection | 0.5ml PFS (1's) | 079275Official source ↗ | No indexed price | — | — |
| Hexaxim Deptheria + Tetanus + Polio + Pertussius + Influenza + Hepatitis BSource observed | — | — | Suspension for injection | 0.5ml PFS (1's) | 079275Official source ↗ | No indexed price | — | — |
| Hoeniva | Chloroquine | 250 mg | Tablet | 500's | 009020 | PKR 1,682.30 | PKR 3.36/tablet | 🔒 Pharma Pro |
| Hoeniva | Chloroquine | 50 mg/5 mL | Syrup | 60ml Bottle | 012004 | PKR 79.19 | PKR 1.32/mL | 🔒 Pharma Pro |
| Imovax Polio | Poliomyelitis vaccine, inactivated | 0.5 mL/dose (40/8/32 DU) | Suspension for injection | 0.5ml PFS (1's) | 045700 | PKR 809.09 | — | No comparator |
| Lantus | Insulin glargine | 100 IU | Injection | 1x10ml vial | 031388 | PKR 6,369.74 | — | No comparator |
| Lantus | Insulin glargine | 100 IU/mL | Prefilled pen injection | 5x3ml | 052294 | PKR 9,342.30 | PKR 622.82/mL | No comparator |
| Lasix | Furosemide | 40 mg | Tablet | 2x50 | 000229 | PKR 458.20 | PKR 4.58/tablet | 🔒 Pharma Pro |
| Lasix | Furosemide | 20 mg/2 mL | Injection | 50x2 mL | 000230 | PKR 702.48 | PKR 7.02/mL | 🔒 Pharma Pro |
All 28 Hoechst Pakistan brands in Pakistan
- Aventriax Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
- Claforan Cefotaxime · 0.5 g injection, 1 g injection, 2 g injection
- Clexane Enoxaparin · 40 mg injection, 60 mg injection, 80 mg injection
- Co-Plavix Clopidogrel + Aspirin · 75 mg + 75 mg tablet
- Cordarone Amiodarone · 100 mg tablet, 150 mg injection, 200 mg tablet
- Critixa Ceftazidime · 2 g/0.5 g injection
- Eloxatin Concentrate Oxaliplatin · 100 mg/20 mL infusion, 50 mg/10 mL infusion
- Flagyl Metronidazole, Metronidazole + Diloxanide furoate · 200 mg tablet, 200 mg/5 mL suspension, 400 mg tablet
- Flagyl Plus Metronidazole + Diloxanide furoate · 200 mg + 250 mg suspension
- Fludara / Fludarabine Phosphate Fludarabine phosphate · 50 mg injection
- Hoeniva Chloroquine · 250 mg tablet, 50 mg/5 mL syrup
- Imovax Polio Poliomyelitis vaccine, inactivated · 0.5 mL/dose (40/8/32 DU) injection
- Lantus Insulin glargine · 100 IU injection, 100 IU/mL injection
- Lasix Furosemide · 20 mg tablet, 20 mg/2 mL injection, 40 mg tablet
- Lasoride Furosemide + Amiloride · 40 mg + 5 mg tablet
- Lignocaine Lidocaine · 1 % injection, 1% injection
- Menactra Meningococcal conjugate vaccine (A, C, Y, W-135) · 4 mcg each serogroup/0.5 mL injection
- Neodipar Metformin · 1 g tablet, 500 mg tablet, 850 mg tablet
- Neodipar s Metformin · 250 mg tablet
- Neodipar SR Metformin · 1 g tablet, 500 mg tablet
- Plavix Clopidogrel · 300 mg tablet, 75 mg tablet
- Stamaril Yellow fever vaccine · ≥1000 LD50 units/0.5 mL vaccine
- Tavanic Levofloxacin · 250 mg tablet, 500 mg tablet
- Taxotere Docetaxel · 20 mg/mL infusion, 80 mg/4 mL infusion
- Toujeo Insulin glargine · 300 units/mL injection
- Vaxigrip Influenza vaccine, inactivated, trivalent · 15 mcg haemagglutinin/strain per 0.5 mL injection
- Vaxigrip Tetra Influenza vaccine (split virion, inactivated, quadrivalent) · 15 mcg haemagglutinin per strain / 0.5 mL dose vaccine
- Verorab Rabies vaccine, inactivated (purified Vero cell) · 2.5 IU/0.5 mL vaccine
Hoechst Pakistan: common questions
How many products does Hoechst Pakistan have in Pakistan?
Hoechst Pakistan Limited has 63 registered medicine presentations in Pakistan, sold under 28 brands and covering 25 generic medicines.
What are the main brands of Hoechst Pakistan?
By number of registered strengths and packs, its largest brands are Flagyl (Metronidazole, Metronidazole + Diloxanide furoate), Aventriax (Ceftriaxone), Claforan (Cefotaxime), Clexane (Enoxaparin) and Cordarone (Amiodarone). This is not a sales ranking.
Which therapy areas does Hoechst Pakistan cover?
The most products are in Anti-infectives (25), Endocrine & metabolic (10), Hematology & thrombosis (7), Cardiovascular (7) and Vaccines & immunologicals (7).
Where can I see Hoechst Pakistan medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.